Coming soon: European Drug Report 2024 to be released on 11 June

How is Europe's opioid market evolving? What substances are causing the most concern today? How are countries responding to cannabis use? Find out more when the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) launches its European Drug Report 2024: Trends and Developments in a live online press conference on 11 June. Based on data from 29 countries (EU 27, Türkiye and Norway), the online report delivers the latest overview of the drug situation in Europe, exploring long-term trends and emerging threats. The comprehensive analysis covers drug use and supply as well as drug-…
Read more

New EMCDDA resource on drug consumption rooms: a local response to local problems and needs

The EMCDDA has released today a new miniguide on drug consumption rooms (DCR) as part of its Health and social responses to drug problems: a European guide. The resource is the first miniguide in a bundle of reports dedicated to drug-related interventions. It provides an overview of key issues related to these facilities, including service delivery, guidance and existing evidence and latest developments in Europe. It also considers implications for policy and practice. DCRs are professionally supervised healthcare facilities (fixed or mobile) where people who use drugs can do so under safer…
Read more

Bursaries offered for Lisbon Addictions 2024 to EMCDDA international cooperation partners

The EMCDDA is delighted to announce the availability of bursaries for Lisbon Addictions 2024. The bursaries are being offered via the agency's international cooperation projects, funded by the European Union. The bursaries will cover the registration fee to the conference, a round trip to Lisbon and pre-paid accommodation. Professionals, academics and experts of the Candidate and Potential candidates to the EU, European Neighbourhood Policy area beneficiaries and Latin America and the Caribbean are eligible to apply. Eligibility criteria: Being a national of one of the following:…
Read more